文献速递免疫规划妇幼与学校卫生

希腊孕妇白喉、破伤风、百日咳抗体血清阳性率与Tdap疫苗接种情况——一项横断面研究

Seroprevalence of diphtheria, tetanus and pertussis antibodies and Tdap vaccination in pregnant women in Greece - A cross- sectional study.
PubMed 文献 · Vaccine · 2024-10-21

2017至2019年在希腊雅典两家妇产医院开展横断面研究,检测253名分娩孕妇白喉、破伤风、百日咳毒素IgG抗体并记录Tdap接种情况。白喉血清阳性率57.7%,百日咳12.5%,破伤风92.7%;仅3/253(1.2%)报告孕期接种Tdap。结论认为白喉和百日咳血清阳性率低、孕期接种率不足2%,许多婴儿出生后最初数月缺乏保护。

要点

  • 253名孕妇中白喉血清阳性率57.7%,百日咳仅12.5%,破伤风92.7%。
  • 白喉血清阳性率最低为≤25岁组38.2%,年龄增长与血清阳性率升高相关(p=0.036)。
  • 仅3/253(1.2%)报告孕期接种Tdap,尽管希腊国家免疫规划推荐孕期接种。

核心结论

  • 孕妇白喉和百日咳血清阳性率低,且尽管希腊国家免疫规划推荐,孕期Tdap接种率不足2%,许多婴儿出生后最初数月缺乏保护。
  • 研究强调亟需开展国家层面的运动以完成儿童期免疫接种,并向公众宣传孕期Tdap接种的安全性和重要性。

研究设计与样本

  • 2017至2019年在希腊雅典两家妇产医院开展的横断面研究,采集分娩孕妇血样并以ELISA试剂盒检测抗白喉、破伤风、百日咳毒素IgG抗体,共分析253份血样及配对问卷。
  • 血清阳性定义:抗白喉和抗破伤风毒素IgG≥0.1,抗百日咳>50 IU/mL;Tdap接种情况由研究对象自我报告。

主要发现

  • 白喉血清阳性率为57.7%,最低为≤25岁年龄组38.2%,年龄增长与血清阳性率升高相关(p=0.036)。
  • 百日咳血清阳性率为12.5%;破伤风血清阳性率为92.7%。
  • 抗百日咳GMT为16.98 IU/mL,抗白喉GMT为0.13 IU/mL,抗破伤风GMT为0.63 IU/mL。
  • 在希腊出生且教育水平较高的女性抗破伤风抗体更高(p=0.004与p=0.004)。
  • 3/253(1.2%)女性报告孕期接种Tdap。

临床怎么用

  • 作者认为研究凸显亟需开展国家层面运动,以完成儿童期免疫接种并向公众宣传孕期Tdap接种的安全性和重要性。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: We performed a cross- sectional study in two maternity hospitals in Athens, Greece between 2017 and 2019 assessing seroprevalence and Geometric Mean Titres (GMTs) of diphtheria, pertussis and tetanus antibodies in pregnant women and recorded adherence to Greek National Immunization Program (NIP) regarding Tdap vaccination in pregnancy. METHODS: Blood samples were collected from women in labour and anti- diphtheria, tetanus and pertussis toxin IgG antibodies were measured by Elisa kits. Seropositivity was defined as anti-diphtheria and anti- tetanus toxin IgG levels ≥0.1, and anti- pertussis >50 IU/mL. Seroprevalence and GMTs were calculated according to demographic factors. Tdap vaccination before and during pregnancy was self-reported by study participants. RESULTS: We analysed 253 blood samples and paired questionnaires. Seropositivity was 57.7 % for diphtheria. The lowest rate (38.2 %) was observed in the youngest age group (≤25 years). Increasing age was associated with higher seroprevalence (p = 0.036). 12.5 % of women were seropositive against pertussis. Most were seropositive for tetanus (92.7 %). Anti-pertussis GMTs were 16.98, anti-diphtheria 0.13 and anti- tetanus GMTs 0.63 IU/mL. Women born in Greece and with higher educational level had higher antibodies against tetanus (p = 0.004 & 0.004 respectively). 3/253 (1.2 %) of women assessed reported Tdap vaccination during pregnancy. CONCLUSION: Seropositivity rates were low for diphtheria and pertussis among pregnant women. In addition, less than 2 % were vaccinated with Tdap despite recommendation by Greek NIP. Therefore, many infants end up unprotected during the first months of life. Our study highlights the urgent need for national campaigns targeting to completion of childhood immunization and information of the public about safety and importance of Tdap vaccination in pregnancy.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Papailiou S, Soldatou A, Marmarinos A, et al. Seroprevalence of diphtheria, tetanus and pertussis antibodies and Tdap vaccination in pregnant women in Greece - A cross- sectional study. Vaccine. 2024. PMID: 39437646. doi:10.1016/j.vaccine.2024.126435

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。